Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Effect of Early Cytomegalovirus Reactivation on Relapse in Adult Patients with Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: A Registry Study from the Japan Society for Transplantation and Cellular Therapy (JSTCT)

Tatsuya Konishi, Kensuke Matsuda, Hidehiro Itonaga, Noriko Doki, Tetsuya Nishida, Ken-Ichi Matsuoka, Takashi Ikeda, Yoshinobu Kanda, Takahiro Fukuda, Junya Kanda, Hirohisa Nakamae, Tatsuo Ichinohe, Yoshiko Atsuta, Ken Ishiyama

Blood (2023) 142 (Supplement 1): 2170.

https://doi.org/10.1182/blood-2023-172414

Published: 2023

Journal Articles

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Blood (2023) 142 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2023-180906

Published: 2023

Journal Articles

Interim Phase I Safety Study of Anti-Transferrin Receptor Antibody(PPMX-T003) in Patients with Polycythemia Vera

Tomoki Ito, Teruhito Takakuwa, Masayuki Hino, Hirohisa Nakamae, Tadashi Matsuura

Blood (2023) 142 (Supplement 1): 1825.

https://doi.org/10.1182/blood-2023-174193

Published: 2023

Journal Articles

Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease

Kaito Harada, Junya Kanda, Masahiro Hirayama, Fumiya Wada, Naoyuki Uchida, Hirohisa Nakamae, Masatsugu Tanaka, Makoto Onizuka, Hiroyuki Ohigashi, Nobuaki Nakano, Takahiro Fukuda, Kazuya Ishiwata, Yumiko Maruyama, Tetsuya Eto, Fumihiko Ishimaru, Yoshiko Atsuta, Hideki Nakasone, Takashi Tanaka

Blood (2023) 142 (Supplement 1): 4905.

https://doi.org/10.1182/blood-2023-184821

Published: 2023

Journal Articles

Efficacy of Cord Blood Transplantation for the Management of Chronic Myelomonocytic Leukemia: A Registry-Based Study in Japan

Blood (2023) 142 (Supplement 1): 3577.

https://doi.org/10.1182/blood-2023-173603

Published: 2023

Journal Articles

CR1 Favors PTCy-haplo over UCB in Allogeneic Stem Cell Transplantation for Adult Patients with AL

Tomoyasu Jo, Tomoaki Ueda, Yu Akahoshi, Tadakazu Kondo, Naoyuki Uchida, Masatsugu Tanaka, Hirohisa Nakamae, Noriko Doki, Shuichi Ota, Masashi Sawa, Hiroyuki Ohigashi, Yumiko Maruyama, Nobuyuki Takayama, Tetsuya Nishida, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yasuyuki Arai

Blood (2023) 142 (Supplement 1): 2175.

https://doi.org/10.1182/blood-2023-182588

Published: 2023

Journal Articles

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

Blood (2023) 142 (11): 1008–1021.

https://doi.org/10.1182/blood.2023019799

Published: 2023

Includes: Supplemental data

Journal Articles

Time-Sequential Change of the Predictive Power of Peripheral Blood WT1mRNA Levels after Allogeneic Stem Cell Transplantation for Myeloid Neoplasm Relapse and Development of a Dynamic Relapse Prediction Model

Soichiro Nakako, Hiroshi Okamura, Isao Yokota, Yukari Umemoto, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Mitsutaka Nishimoto, Asao Hirose, Mika Nakamae, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae

Blood (2022) 140 (Supplement 1): 3416–3418.

https://doi.org/10.1182/blood-2022-164932

Published: 2022

Journal Articles

The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data

Blood (2021) 138 (Supplement 1): 3965.

https://doi.org/10.1182/blood-2021-147046

Published: 2021

Journal Articles

Cytomegalovirus Gastroenteritis in Patients with Acute Graft-Versus-Host Disease

Yu Akahoshi, Shun-ichi Kimura, Yuma Tada, Toshihiro Matsukawa, Masaharu Tamaki, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Hirohisa Nakamae, Takuro Kuriyama, Ken-ichi Matsuoka, Takashi Ikeda, Takafumi Kimura, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Murata, Seitaro Terakura, Hideki Nakasone

Blood (2021) 138 (Supplement 1): 3918.

https://doi.org/10.1182/blood-2021-147658

Published: 2021

Journal Articles

A Prospective Comparison Analysis of Blood Biomarkers for the Diagnosis and Prediction of Sinusoidal Obstruction Syndrome

Naonori Harada, Hiroshi Okamura, Hideo Koh, Nao Tanizawa, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Asao Hirose, Mika Nakamae, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hirohisa Nakamae, Masayuki Hino

Blood (2021) 138 (Supplement 1): 2865.

https://doi.org/10.1182/blood-2021-146497

Published: 2021

Journal Articles

Outcomes of Haploidentical Salvage Transplantation Using Post-Transplant Cyclophosphamide for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation

Kaito Harada, Shigeo Fuji, Yuho Najima, Motohiro Kato, Akihito Shinohara, Masako Toyosaki, Hirohisa Nakamae, Daisuke Hasegawa, Hiroatsu Iida, Makoto Onizuka, Yoshiko Hashii, Tatsuo Ichinohe, Yoshiko Atsuta, Hideki Nakasone

Blood (2021) 138 (Supplement 1): 2871.

https://doi.org/10.1182/blood-2021-149549

Published: 2021

Journal Articles

Pretransplant Plasma Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide Are More Useful Prognostic Markers of Overall Survival after Allogeneic Hematopoietic Cell Transplantation Than Echocardiography

Naonori Harada, Hiroshi Okamura, MD PhD, Takahiko Nakane, MD PhD, Shiro Koh, MDPhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Hideo Koh, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134223

Published: 2020

Journal Articles

Impact of Donor KIR and HLA Genotypes on Clinical Outcomes According to Pre-Transplant Remission Status after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Kentaro Ido, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Shiro Koh, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 2030.

https://doi.org/10.1182/blood-2019-125173

Published: 2019

Journal Articles

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Nao Tanizawa, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Koh Shiro, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 4492.

https://doi.org/10.1182/blood-2019-124264

Published: 2019

Journal Articles

Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT

Yoshinobu Maeda, MD PhD, Tomotaka Ugai, MD, Eisei Kondo, Kazuhiro Ikegame, MD PhD, Makoto Murata, MD PhD, Naoyuki Uchida, MD PhD, Toshihiro Miyamoto, MD PhD, Satoshi Takahashi, MD PhD, Kazuteru Ohashi, MD PhD, Hirohisa Nakamae, MD PhD, Makoto Hirokawa, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD, Junya Kanda, MD

Blood (2018) 132 (Supplement 1): 4635.

https://doi.org/10.1182/blood-2018-99-112796

Published: 2018

Journal Articles

Comparable Survival Outcomes of Haploidentical Stem Cell Transplantation and Unrelated Bone Marrow Transplantation

Junichi Sugita, Yoshiko Atsuta, MD PhD, Mio Kurata, Hirohisa Nakamae, Naoki Kurita, Ken Ishiyama, MD PhD, Souichi Shiratori, Takahiro Fukuda, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Takanori Teshima

Blood (2018) 132 (Supplement 1): 4644.

https://doi.org/10.1182/blood-2018-99-114770

Published: 2018

Journal Articles

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Naonori Harada, Takahiko Nakane, MD PhD, Mika Nakamae, MD PhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Yasunobu Takeoka, MD PhD, Asao Hirose, MD PhD, Yasuhiro Nakashima, MD PhD, Hideo Koh, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2018) 132 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2018-99-111679

Published: 2018

Journal Articles

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Kentaro Ido, MD, Mika Nakamae, MDPhD, Hideo Koh, MDPhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MDPhD, Yoshinori Hashimoto, MD, Yasunobu Takeoka, MDPhD, Asao Hirose, MDPhD, Yasuhiro Nakashima, MDPhD, Takahiko Nakane, MD PhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD

Blood (2018) 132 (Supplement 1): 4665.

https://doi.org/10.1182/blood-2018-99-111834

Published: 2018

Journal Articles

Would Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation?

Hideki Nakasone, MD PhD, Koji Kawamura, MD PhD, Kimikazu Yakushijin, MD, Akihito Shinohara, MD PhD, Heiwa Kanamori, MD PhD, Kazuteru Ohashi, MD PhD, Takahiro Fukuda, MD PhD, Naoyuki Uchida, MD PhD, Hirohisa Nakamae, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshihiro Inamoto, MD PhD, Sachiko Seo, MD PhD, Fumihiko Kimura, Prof, MD PhD, Masao Ogata, MD PhD

Blood (2018) 132 (Supplement 1): 4669.

https://doi.org/10.1182/blood-2018-99-113790

Published: 2018

NARROW

Effect of Early Cytomegalovirus Reactivation on Relapse in Adult Patients with Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: A Registry Study from the Japan Society for Transplantation and Cellular Therapy (JSTCT)

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Interim Phase I Safety Study of Anti-Transferrin Receptor Antibody(PPMX-T003) in Patients with Polycythemia Vera

Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease

Efficacy of Cord Blood Transplantation for the Management of Chronic Myelomonocytic Leukemia: A Registry-Based Study in Japan

CR1 Favors PTCy-haplo over UCB in Allogeneic Stem Cell Transplantation for Adult Patients with AL

Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect

Time-Sequential Change of the Predictive Power of Peripheral Blood WT1mRNA Levels after Allogeneic Stem Cell Transplantation for Myeloid Neoplasm Relapse and Development of a Dynamic Relapse Prediction Model

The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data

Cytomegalovirus Gastroenteritis in Patients with Acute Graft-Versus-Host Disease

A Prospective Comparison Analysis of Blood Biomarkers for the Diagnosis and Prediction of Sinusoidal Obstruction Syndrome

Outcomes of Haploidentical Salvage Transplantation Using Post-Transplant Cyclophosphamide for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation

Pretransplant Plasma Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide Are More Useful Prognostic Markers of Overall Survival after Allogeneic Hematopoietic Cell Transplantation Than Echocardiography

Impact of Donor KIR and HLA Genotypes on Clinical Outcomes According to Pre-Transplant Remission Status after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Who Is the Best Donor for the Second Transplant?: HLA Discrepancy between Graft and Host Rather Than That Graft and First Donor May Impact the Second Transplant Outcome from the JSHCT

Comparable Survival Outcomes of Haploidentical Stem Cell Transplantation and Unrelated Bone Marrow Transplantation

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Would Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only